CD86 and neoplasm: Immunohistochemical staining for CD80 and CD86 (activated dendritic cells markers) was performed in representative cases, which showed strong positivity at the tumor stromal interface in activated tumors but not in suppressed tumors (Fig. 2c,d), supporting the RNA-Seq findings.